Suven Life Sciences gets 2 new US patents

22 Sep 2010 Evaluate

Suven Life Sciences has received patents from the US for two new chemical entities (NCEs) used in treating disorders associated with the central nervous system. With the patents valid till 2022, the products of these inventions may be out-licensed at various phases of clinical trials.

 

The two patents include selective compounds discovered by Suven that are useful in treatment of disorders like Alzheimer’s disease, Parkinson, Schizophrenia and Attention Deficient Hyperactivity Disorder.The market for the cognitive disorders in the Central Nervous System arena has an estimated $ 30 billion market potential globally.

crackcrack

Suven Life Sciences Share Price

133.50 -3.40 (-2.48%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×